Randomized Trial: Restarting Antiplatelet Therapy Safe after Intracerebral Hemorrhage

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial – The Lancet (free)

Commentaries: Restarting antiplatelet therapy after intracerebral haemorrhage – The Lancet (free) AND Aspirin unlikely to cause more brain bleeds for stroke patients – UPI (free) AND Aspirin green light for brain bleed stroke patients, study suggests – University of Edinburgh (free)

“The risk of recurrent intracerebral hemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention.”